GlassScriptPhysician profile
Leslie Caryn Hoffman
NPI 1891858312
$2,650.56
in general payments reported to CMS, 2019-2025
39 companies · $300 in 2025
The $300 reported for 2025 was less than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $606 · 2020: $293 · 2021: $700 · 2022: $390 · 2023: $159 · 2024: $204 · 2025: $300.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $662.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $661.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $322.79 | 2019-2025 | Tepezza, Repatha, Repatha |
| Novo Nordisk INC | $275.72 | 2019-2022 | |
| Abbvie INC. | $250.68 | 2019-2024 | |
| Sanofi-Aventis U.S. LLC | $234.63 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $168.50 | 2021-2023 | |
| Xeris Pharmaceuticals, INC. | $160.82 | 2020-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $141.90 | 2019-2025 | Jardiance |
| Dexcom, INC. | $141.19 | 2019-2024 | Dexcom G6 Transmitter |
| Lifescan, INC. | $82.50 | 2019-2020 | |
| Lilly USA, LLC | $75.52 | 2019-2022 | |
| Corcept Therapeutics | $57.76 | 2023-2024 | Korlym |
| Amarin Pharma, INC. | $56.58 | 2020-2021 | |
| Antares Pharma, INC. | $55.44 | 2020-2025 | Xyosted |
| Astrazeneca Pharmaceuticals LP | $53.71 | 2019-2022 | |
| Almatica Pharma LLC | $50.54 | 2024-2025 | Teriparatide |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leslie Hoffman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.